CARDIAC PACEMAKERS, INC.;MUSC Foundation for Research Development
发明人:
Craig M. Stolen,Timothy E. Meyer,Milan Seth,Francis G. Spinale,Nicholas David Wold
申请号：
US13756129
公开号：
US10502747B2
申请日:
2013.01.31
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Embodiments of the disclosure are related to systems and methods for utilizing biomarker panel data with respect to medical devices and methods, amongst other things. In an embodiment, the disclosure can include a method of predicting the likelihood of response to CRT therapy. The method can include quantifying levels of one or more biomarkers in a biological sample of a patient, analyzing the quantified levels to determine response to CRT therapy, wherein a panel of biomarkers includes at least two selected from the group consisting of CRP, SGP-130, sIL-2R, sTNFR-II, IFNg, BNP, sST2, MMP-2, MMP-9, TIMP-1, TIMP-2, TIMP-4. Other embodiments are also included herein.
